User login
Key clinical point: Ultrasound detected subclinical inflammation in the wrist joints of most patients with rheumatoid arthritis (RA) in clinical remission or with lower disease activity, with the risk for subclinical inflammation being lower among those using biologic therapy.
Major finding: Overall, subclinical inflammation was detected in 57.4% of the patients in complete remission or with lower disease activity. Factors negatively associated with subclinical inflammation included the use of biologic therapy (odds ratio [OR] 0.59; P = .001), methotrexate (OR 0.83; P = .020), and glucocorticoids (OR 0.60; P = .001) and alcohol consumption (OR 0.55; P = .006).
Study details: This cross-sectional study included 1248 patients with RA who underwent gray scale and power Doppler ultrasound assessments of the dorsal radiolunate joints of both wrists.
Disclosures: This study was supported by the Kaohsiung Chang Gung Memorial Hospital, Taiwan, and other sources. The authors declared no conflicts of interest.
Source: Wang YW et al. Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity—A RA ultrasound registry study. BMC Musculoskelet Disord. 2023;24:438 (May 30). doi: 10.1186/s12891-023-06521-8
Key clinical point: Ultrasound detected subclinical inflammation in the wrist joints of most patients with rheumatoid arthritis (RA) in clinical remission or with lower disease activity, with the risk for subclinical inflammation being lower among those using biologic therapy.
Major finding: Overall, subclinical inflammation was detected in 57.4% of the patients in complete remission or with lower disease activity. Factors negatively associated with subclinical inflammation included the use of biologic therapy (odds ratio [OR] 0.59; P = .001), methotrexate (OR 0.83; P = .020), and glucocorticoids (OR 0.60; P = .001) and alcohol consumption (OR 0.55; P = .006).
Study details: This cross-sectional study included 1248 patients with RA who underwent gray scale and power Doppler ultrasound assessments of the dorsal radiolunate joints of both wrists.
Disclosures: This study was supported by the Kaohsiung Chang Gung Memorial Hospital, Taiwan, and other sources. The authors declared no conflicts of interest.
Source: Wang YW et al. Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity—A RA ultrasound registry study. BMC Musculoskelet Disord. 2023;24:438 (May 30). doi: 10.1186/s12891-023-06521-8
Key clinical point: Ultrasound detected subclinical inflammation in the wrist joints of most patients with rheumatoid arthritis (RA) in clinical remission or with lower disease activity, with the risk for subclinical inflammation being lower among those using biologic therapy.
Major finding: Overall, subclinical inflammation was detected in 57.4% of the patients in complete remission or with lower disease activity. Factors negatively associated with subclinical inflammation included the use of biologic therapy (odds ratio [OR] 0.59; P = .001), methotrexate (OR 0.83; P = .020), and glucocorticoids (OR 0.60; P = .001) and alcohol consumption (OR 0.55; P = .006).
Study details: This cross-sectional study included 1248 patients with RA who underwent gray scale and power Doppler ultrasound assessments of the dorsal radiolunate joints of both wrists.
Disclosures: This study was supported by the Kaohsiung Chang Gung Memorial Hospital, Taiwan, and other sources. The authors declared no conflicts of interest.
Source: Wang YW et al. Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity—A RA ultrasound registry study. BMC Musculoskelet Disord. 2023;24:438 (May 30). doi: 10.1186/s12891-023-06521-8